Exercise intolerance is an important comorbidity in patients with CKD. Anaerobic threshold (AT) determines the upper limits of aerobic exercise and is a measure of cardiovascular reserve. This study investigated the prognostic capacity of AT on survival in patients with advanced CKD and the effect of kidney transplantation on survival in those with reduced cardiovascular reserve. Using cardiopulmonary exercise testing, cardiovascular reserve was evaluated in 240 patients who were waitlisted for kidney transplantation between 2008 and 2010, and patients were followed for #5 years. Survival time was the primary endpoint. Cumulative survival for the entire cohort was 72.6% (24 deaths), with cardiovascular events being the most common cause of death (54.2%). According to Kaplan-Meier estimates, patients with AT ,40% of predicted peak VO 2 had a significantly reduced 5-year cumulative overall survival rate compared with those with AT $40% (P,0.001). Regarding the cohort with AT ,40%, patients who underwent kidney transplantation (6 deaths) had significantly better survival compared with nontransplanted patients (17 deaths) (hazard ratio, 4.48; 95% confidence interval, 1.78 to 11.38; P=0.002). Survival did not differ significantly among patients with AT $40%, with one death in the nontransplanted group and no deaths in the transplanted group. In summary, this is the first prospective study to demonstrate a significant association of AT, as the objective index of cardiovascular reserve, with survival in patients with advanced CKD. High-risk patients with reduced cardiovascular reserve had a better survival rate after receiving a kidney transplant.
Exercise intolerance is an important comorbid factor, in addition to the excess cardiovascular burden complicating patients with advanced CKD. [1] [2] [3] Exercise capacity relies on the health of the circulatory system in sustaining oxygen and carbon dioxide transport between the cellular and pulmonary systems. 4 A reduction in exercise capacity thus limits the range of physical activities that a patient can accomplish. The importance of this is underscored by a previously reported association between mortality and physical activity assessed through questionnaires in CKD patients. 5, 6 However, such an evaluation is limited due to its subjectivity and its inability to provide any information on cardiovascular reserve, thereby failing to accurately estimate response capacity to physiologic stress of exercise. On the contrary, quantification of cardiovascular reserve through graded exercise has been shown to be powerful given its unique ability to predict the capacity to survive pathologic stresses in various chronic conditions such as heart failure and chronic lung disease 4, [7] [8] [9] as well as in perioperative demands of major surgeries. [10] [11] [12] During exercise, alveolar oxygen uptake (VO 2 ) provides the arterial oxygen for delivery to contracting muscles reflecting the coupling of pulmonary gas exchange to cellular respiration by the circulation. 13 Above a certain work rate, exercise sustainability through the aerobic regeneration of ATP is supplemented by anaerobic glycolysis resulting in production of lactic acid. The corresponding VO 2 at which blood lactate begins to rise defines the point of anaerobic threshold (AT), which can be measured noninvasively by cardiopulmonary exercise testing (CPET). 13, 14 AT therefore represents the upper limit of exercise workloads beyond which prolonged exercise is not possible. 4 It is an objective marker of cardiovascular reserve that is both reproducible and independent of the patient's effort. 4, 9, 15 The corresponding VO 2 at the point of AT normally averages at 50%-60% of predicted peak VO 2 in healthy sedentary individuals, 4, 13, 15, 16 and AT ,40% of predicted peak VO 2 is indicative of circulatory insufficiency. 4, 13, 17 Previous studies have established the association of AT with reduced cardiac output 18 and its strength as an independent predictor of survival in patients with chronic heart failure. 9 Despite the increasing recognition that patients with CKD carry excess and complex cardiovascular burdens of premature arterial calcification, endothelial dysfunction, increased left ventricular mass, and myocardial fibrosis, 1-3 it remains unknown whether AT has a similar prognostic capability among this population. Currently, kidney transplantation is the only treatment that offers survival advantage over other forms of renal replacement therapy. However, it is unclear whether such benefit applies to patients with poor cardiovascular reserve.
In this study, we sought to investigate whether AT ,40% of predicted peak VO 2 , as an index of poor cardiovascular reserve, is associated with an increased mortality rate in patients with advanced CKD who were candidates for kidney transplantation. Furthermore, we hypothesized that survival in patients with poor cardiovascular reserve was better among those who received a kidney transplant compared with those who were still waiting for a transplant.
RESULTS

Patient Outcomes
All 240 CKD patients were followed for up to 5 years (median 38 months). A total of 24 patients (10%) died within the follow-up period, with cardiovascular events as the main cause of death (54.2%), followed by infection (25%), malignancy (16.7%), and other causes (cerebrovascular accident, 4.1%). The cumulative event-free survival rate for the whole study population was 72.6%. During the course of follow-up, 124 patients (51.7%) received a kidney transplant. These patients had a lower AT at study entry than those who had not yet received a transplant (mean 6 SD 37.1%68.7% versus 40.4%610.5% predicted peak VO 2 ; P=0.01).
Clinical Characteristics
Baseline descriptive characteristics of the study cohort categorized to groups of survivors and nonsurvivors are presented in Table 1 . Both groups were of similar age, sex, and body mass index (BMI). Relative to the group who survived, the nonsurvivors had a significantly greater history of previous cardiovascular disease (CVD) (P=0.002) and a higher proportion with dialysis vintage .1 year (P=0.01). However, there were no significant differences in the prevalence of other major risk factors such as diabetes, CKD duration, dyslipidemia, and hypertension between the groups. Low serum albumin (P=0.01) and high C-reactive protein (CRP) (P=0.01) were more prevalent among those who died compared with the survivors. Chronic atrial fibrillation was present in only three patients (1.3% Data are presented as the mean 6 SD, median (IQR), or n (%), and are analyzed using the independent samples t test, Mann-Whitney U test, or chisquared test. URR and Kt/V urea are measures of hemodialysis and peritoneal dialysis adequacy, respectively, for dialysis-dependent patients, and E/A is the ratio of mitral peak early filling to late filling velocities. *P,0.05.
patients who were alive, the differences were nonsignificant. The dimensions of the left ventricle at end-diastole (LVIDd) and the left atrium were not significantly different between the groups.
CPET Differentiates between Survivors and Nonsurvivors All patients performed maximal exercises that were accompanied by a respiratory exchange ratio (RER), an objective marker of fatigue .1.15. The mean RER at the point of AT for the study population was 0.960.1. Measurements of cardiovascular reserve (peak VO 2 , peak VO 2 % predicted, absolute AT, AT as % predicted peak VO 2 ) at study entry were significantly lower in nonsurvivors than survivors ( Table 2 ). Survivors achieved a longer endurance time than nonsurvivors (10.461.9 minutes versus 9.461.7 minutes; P=0.02) but the difference in work load was not statistically significant (108645.6 Watt versus 92639.9 Watt; P=0.08).
Cardiovascular Reserve Predicts Patient Survival
The 5-year cumulative survival rates from all-cause mortality were 94.4% in patients with AT $40% predicted peak VO 2 and 46.6% in those with AT ,40% predicted peak VO 2 (P,0.001) ( Figure 1 ). According to the tertiles of AT, the cumulative survival rates were 38.5%, 67.1%, and 100% in groups of AT ,9.4, 9.4-11.4, and .11.4 ml/min per kilogram, respectively (P,0.001) (Supplemental Figure 1) . For cardiovascular death, the 5-year cumulative survival rates were 95.3% in those with AT $40% predicted peak VO 2 and 71.3% in patients with AT ,40% predicted peak VO 2 (P=0.02) (Supplemental Figure 2A) .
Patients with Reduced Cardiovascular Reserve Have Improved Survival after Kidney Transplantation
Of the cohort, 135 patients (56.3%) had baseline AT ,40% of predicted peak VO 2 . Among these patients, 78 (57.8%) received a kidney transplant during the course of follow-up. The overall survival rates for patients with reduced AT were significantly better in those who had a kidney transplant compared with those who did not ( Figure 2A ). The cumulative survival rate in patients with reduced AT but without a kidney transplant was 22.9% compared with 76.8% in those with a transplant (P,0.001). The subgroup analysis of only patients with reduced AT suggests that survival in this apparently highrisk cohort is reduced with kidney transplantation, with 17 deaths in the nontransplanted group compared with 6 deaths in the transplanted group (hazard ratio [HR], 4.48; 95% confidence interval [95% CI], 1.78 to 11.38; P=0.002) ( Figure 2B ). Among 105 patients with AT $40%, there was only 1 death in the nontransplanted group compared with none in the transplanted group (Figure 2A ).
Despite the low AT, lower cardiovascular mortality rate was also observed in transplanted patients versus nontransplanted patients (P=0.001) (Supplemental Figure 2B ). Table 3 presents the results of the Cox proportional hazards model that demonstrate that AT, LVEF, prior CVD, dialysis vintage .1 year, no kidney transplant, serum albumin, and CRP are significant independent predictors of all-cause mortality. Among these, AT was the strongest predictor; the crude HR increase per 1% of predicted peak VO 2 was 0.88 (95% CI, 0.83 to 0.93; P,0.001). Figure 3 presents the receiver operator characteristic (ROC) curves for the continuous risk factors and sensitivity-specificity measures for the binary risk factors. Among these risk variables, AT had the largest area under the ROC curve (AUC) of 0.82 (95% CI, 0.73 to 0.90), indicating its capacity to accurately predict patients at risk of death. Multivariate analysis showed that AT (P,0.001) and kidney transplant (P=0.03) were significant predictors of outcome after adjustment for age, sex, LVEF, hypertension, diabetes, prior CVD, CKD duration, dialysis .1 year, serum albumin, and CRP (Table 4 , model 1). The final model (Table 4 , model 2) highlighted only AT (P,0.001) and kidney transplant (P=0.002) as significant predictors of outcome. All other variables that were significant in the univariate analysis were no longer significant in the multivariate model. Model-building strategies of forward selection, backward elimination, and stepwise variable selection were utilized and resulted in the same final model. Furthermore, Cox regression analysis on the subset of patients with AT ,40% of predicted peak VO 2 demonstrated that those who received a kidney transplant had a significantly reduced hazard of death (Table 4, 
Univariate and Multivariate Predictors of Survival
DISCUSSION
To the best of our knowledge, this is the first prospective study to demonstrate an association between exercise AT as the objective index of cardiovascular reserve and survival in patients with advanced CKD. Our cohort was on the kidney transplant waiting list at entry into the study and was observed for a period lasting as long as 5 years. More than half (56.3%) of these patients had objective evidence of reduced cardiovascular reserve defined by having an AT of ,40% of predicted peak VO 2 . Deaths were recorded in 10% of the study population during the follow-up period and a cardiovascular event was the leading cause of mortality as noted in previous studies. 19, 20 The main finding of this study is the significant association between AT measured at study entry and all-cause mortality, independent of age, sex, and established CKD comorbid predictors. The importance of this is underscored by the finding that AT reflects the functional health of the overall circulatory system 9,13,17 which, in CKD, is subjected to the additional effects of azotemia with complex consequences such as myocardial fibrosis, arteriosclerosis, and left ventricular hypertrophy. 1, 3, 21 Although most of the established clinicopathologic factors were found to be significant independent predictors of poor outcome, their nonsignificance in the multivariate model reflected the limitation of single surrogate parameters in risk stratification of the CKD population. Patients deemed suitable for kidney transplantation were generally considered healthier, on the basis of their younger age and lower prevalence of comorbidities compared with those who were excluded. 22 This may also be the reason for the lack of association between age and diabetes with the risk of death in our study population. However, failure to prioritize these single surrogate risk factors was further highlighted by previous attempts to develop risk prediction models that incorporated several CKD-related comorbidity indices. 23, 24 On the contrary, this study has shown that quantification of cardiovascular reserve by the measure of AT is not only a significant independent predictor of all-cause mortality, but remained as a powerful predictor of death even after adjusting for known comorbid factors. The accuracy of AT as a prognostic factor in the CKD cohort is also demonstrated in the ROC curve analyses (Figures 4 and 5) .
The decreased overall survival rates observed in patients with reduced AT (Figure 1 and Supplemental Figure 1 ) highlights an inverse relationship between the graded severity of AT and mortality. The results of this study also showed a similar trend in the higher cardiovascular mortality rate in patients with AT ,40% compared with those with AT $40% of predicted peak VO 2 (Supplemental Figure 2A) . These findings support the notion that the level of cardiovascular reserve measured through the induction of incremental exercise workload corresponds to the ability of patients to hold out against or survive pathologic stress of chronic conditions (e.g., CKD and its associated comorbidities) as previously suggested by studies of patients with heart failure. 9, 25 Several studies have reported the association of habitual physical inactivity in CKD patients with a high mortality risk. 6, [26] [27] [28] Despite the finding that the death rate was greater in inactive individuals compared with those with increased physical activity, no studies had yet recognized that physical inactivity in a CKD cohort could be related to exercise intolerance due to pathologically impaired cardiovascular reserve. In this study, we utilized a maximal individualized ramping exercise protocol because submaximal CPET-derived indices of cardiovascular reserve may be further limited by an individual's determination or muscle deconditioning. Quantification of cardiovascular reserve using AT can be done accurately 13, 29 and is also advantageous due to its independence to a patient's effort or premature termination of exercise test. 9 In addition, exercise beyond the attainment of AT helps distinguished impaired cardiovascular reserve from noncardiac (pulmonary or musculoskeletal) causes of exercise limitations. 30 The extent to which oxygen uptake matches cellular oxygen consumption reflects the effectiveness of oxygen delivery via the circulation. 14 Continual of exercise against incremental load beyond the point of AT results in nonmetabolic production of carbon dioxide and an increase in the RER .1. Build-up of lactate in exercising muscle causes progressive exercise to be uncomfortable and relates directly to the RER. 31 In this study, all participants successfully completed maximal exercise testing that was accompanied by the attainment of peak exercise RER .1.15, indicative of maximal effort. In addition, the measure of AT (% of predicted peak VO 2 ) was also found to correlate with LVMI (Pearson correlation coefficient, r=20.16; P=0.02) and LVEF (r=0.15; P=0.03). The correlation between AT and changes in left ventricular morphology when analyzed as a continuous variable suggests that small alterations in single surrogate markers may be insignificant independently, however, they exacerbate the circulatory system in combination. The resulting limits in the cardiovascular reserve can therefore be exposed through CPETevaluation of the AT, as shown in this study. Using CPET to evaluate exercise AT, more than half of our cohort participants who were all candidates for transplantation at study entry were found to have poor cardiovascular reserve. There was a trend toward greater LVMI (P=0.02), lower LVEF (P=0.04), and a higher proportion with dialysis vintage .1 year (P=0.05) in this high-risk group compared with patients with AT .40%. The latter group was surprisingly older but the distribution of major clinical risk factors such as diabetes and prior CVD were similar between the groups (Supplemental Table 1 ). Despite this, our results demonstrate that kidney transplantation improves overall longevity ( Figure 2 ) and reduces the rates of cardiovascular death in these high-risk patients with poor cardiovascular reserve (Supplemental Figure  2) . Although a similar survival benefit of transplantation over those who remained on the waiting list was previously reported in a large cohort study by Wolfe et al., 22, 32 it was not known whether the high mortality among the waitlisted might be attributed to poor cardiovascular reserve.
Assessment of cardiovascular reserve using CPET was only done at a single time point at study entry and fluctuation in this measure with time was possible. However, a large effort was made to ensure that all hemodialysis-dependent patients were tested on the first nondialysis day, at least 12 hours after the last dialysis session to ensure consistency of data. 33, 34 Furthermore, this study demonstrates that poor cardiovascular reserve reflected the patient's ability to survive their CKD with its associated comorbidities. In addition, CPET allows the interrogation of the cardiovascular system with incremental physiologic stress providing global and functional end points that stands in contrast to the static morphologic and semi-functional information derived from standard cardiac evaluation tools. This study does not address the potential effect of any specific coronary evaluation modalities. The relevance of coronary artery disease was considered by the documentation of events of coronary artery disease including revascularization therapy as a comorbid factor. Questions remain regarding whether CPET quantification of cardiovascular reserve could allow identification of a subgroup of patients who would benefit from a timely kidney transplantation to maximize the survival benefits or if the measure of AT could improve the transplant work-up process and increase the inclusion of patients into the transplant program, who are otherwise excluded on the basis of current clinical criteria.
In conclusion, this study suggests that AT as the objective index of cardiovascular reserve is a predictor of survival in patients with advanced CKD. Remarkably, the survival benefits of kidney transplantation extend to patients who are at high risk of death due to poor cardiovascular reserve. Further research to improve risk stratification of the CKD population is needed, and this requires characterization of changes in cardiovascular reserve over time for patients being evaluated as potential candidates for kidney transplantation as well as for waitlisted and post-transplant patients.
CONCISE METHODS
Patient Population
Maximal, symptom-limited CPET was added to the routine assessment as part of cardiovascular risk assessment of all patients already on the transplant waiting list or waitlisted at the University Hospitals of Coventry and Warwickshire National Health Service Trust, United Kingdom, between January 1, 2008 and December 31, 2010. The study adhered to the Declaration of Helsinki. Informed consent was obtained from all patients. After the exclusion of 6 patients (unable to cycle due to physical limitations), the study included 240 patients who completed the CPET. Baseline demographics, clinical evaluation, and blood sampling were done before exercise testing. Standard transthoracic echocardiography was performed within a week of the CPET. Prespecified data elements of exercise testing and echocardiography were prospectively obtained. No patient was removed or denied access to the transplant waiting list or denied a renal transplant because of data obtained from CPET.
CKD-related comorbidities were grouped as described in the Supplemental Methods.
CPET
All patients performed upright bicycle exercise testing to maximal tolerance using a cycle ergometer ramping protocol, incorporating an individualized work rate. Breath-by-breath gas exchange analysis (VIASYS; MasterScreen CPX, Hoechberg, Germany) was performed. Before each test, the equipment was calibrated using standard reference gases and a 3-L syringe. The test was terminated at maximal exhaustion, accompanied by attainment of a RER (ratio of CO 2 production to O 2 consumption) of $1.15. Individualized predicted peak VO 2 was calculated according to the formula proposed by Wasserman et al. 13 The VO 2 at the point of AT was determined by the V-slope Cardiovascular Reserve and Survival in CKD patients method in conjunction with analyses of the ventilatory equivalents (VE/VO 2 and VE/VCO 2 ) and end-tidal gas tension (P ET O 2 and P ET CO 2 ) plots. 13 The corresponding milliliters of VO 2 per minute at AT was expressed as a percentage of predicted peak VO 2 . 4, 15, 17 The latter, which adjusts for age, sex, weight, and height, was considered as our primary CPET outcome variable.
Outcome
The primary outcome measure was all-cause mortality, compared between patients with AT ,40% and AT $40% of predicted peak VO 2 . Information on vital status of patients was determined through information from our center and the patients' primary care physician. Primary causes of death were determined from these sources and, where necessary, obtained from the UK Death Registry. The date and cause of death were documented in all cases.
Statistical Analyses
Data were summarized as the mean, median, or frequency, depending on the distribution and type of the variable. Between-group comparisons for these were analyzed using independent samples t tests, Mann-Whitney U tests, or chi-squared tests. Cumulative survival curves of all-cause and cardiovascular mortalities were constructed according to the KaplanMeier estimator and differences between curves were tested for significance by means of log-rank tests. Patients were categorized according to AT, using ,40% predicted peak VO 2 as the cut-off point. Survival time was also analyzed using Cox proportional hazards models to estimate the independent prognostic capability of AT. For AT and each of the established CKD-related risk factors, a ROC curve and sensitivity-specificity analysis for all-cause mortality was performed for continuous and binary variables, respectively. To evaluate the accuracy of the models derived from Cox regression analysis, ordinary ROC curves, and AUC estimates were calculated. All analyses were conducted in accordance with the intention-to-treat principle. Compliance with the proportional hazards assumption was sufficient in all scenarios. The last follow-up period in the entire cohort was August 1, 2012. All statistical analyses were performed using SAS software (version 9.3; SAS Institute Inc., Cary, NC).
